Clinical Best Solutions Sp. z o.o. S.K.
- Address
- Ul. Cicha 4/1, 20-078 Lublin, Poland
Clinical Best Solutions Sp. z o.o. S.K.
Clinical Best Solutions is a specialized research center dedicated to advancing therapeutic interventions for dermatological and neurological conditions. The center demonstrates particular expertise in conducting Phase 3 clinical trials, with a strong focus on evaluating novel biologics and therapeutic agents for chronic inflammatory skin conditions and seizure disorders.
- Atopic dermatitis and eczema, including moderate-to-severe presentations and specialized conditions such as atopic hand eczema
- Monotherapy and adjunctive treatment approaches for chronic inflammatory conditions
- Epilepsy management, focusing on focal onset seizures with add-on therapeutic strategies
The center's research portfolio emphasizes comprehensive evaluation of both efficacy and safety profiles of investigational therapies, including advanced biologics such as rocatinlimab and tralokinumab. With expertise spanning both adolescent and adult populations, Clinical Best Solutions contributes to the development of treatments for patients who are candidates for systemic therapy, utilizing validated assessment tools and standardized outcome measures to ensure robust clinical evidence generation.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 1 by active trials.
- 1Amgen Inc.1active
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1Amgen Inc.2trials
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 1 624 other sites in Poland
Therapeutic Area Benchmark — Poland
Select a therapeutic area to compare against other sites in Poland.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Poland
Market Share
Country: Poland
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Clinical Best Solutions Sp. z o.o. S.K.
lock Showing 1 of 4 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A Phase 3, Open-label, 52-week Study to Assess the Safety, Tolerability, and Efficacy of Rocatinlimab (AMG 451) in Adolescent Subjects Aged ≥ 12 to < 18 years With Moderate-to-severe Atopic Dermatitis (AD) (ROCKET-Orbit) | Amgen Inc. | Phase III | Not Yet Recruiting | — | — |
IMP list
lock Showing 1 of 3 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Rocatinlimab | 2 | Unknown | 2023-04-25 | 2023-04-25 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.